My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 356

    1.

    Abnormalities of retinal metabolism in diabetes and experimental galactosemia. VII. Effect of long-term administration of antioxidants on the development of retinopathy.

    Kowluru RA, Tang J, Kern TS.

    Diabetes. 2001 Aug;50(8):1938-42.PMID: 11473058 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Diabetes-induced activation of nuclear transcriptional factor in the retina, and its inhibition by antioxidants.

    Kowluru RA, Koppolu P, Chakrabarti S, Chen S.

    Free Radic Res. 2003 Nov;37(11):1169-80.PMID: 14703729 [PubMed - indexed for MEDLINE]Related articles

    3.

    Abnormalities of retinal metabolism in diabetes or experimental galactosemia. VI. Comparison of retinal and cerebral cortex metabolism, and effects of antioxidant therapy.

    Kowluru RA, Engerman RL, Kern TS.

    Free Radic Biol Med. 1999 Feb;26(3-4):371-8.PMID: 9895229 [PubMed - indexed for MEDLINE]Related articles

    4.

    Abnormalities of retinal metabolism in diabetes or experimental galactosemia. III. Effects of antioxidants.

    Kowluru RA, Kern TS, Engerman RL, Armstrong D.

    Diabetes. 1996 Sep;45(9):1233-7.PMID: 8772728 [PubMed - indexed for MEDLINE]Related articles

    5.

    Diabetes-induced activation of caspase-3 in retina: effect of antioxidant therapy.

    Kowluru RA, Koppolu P.

    Free Radic Res. 2002 Sep;36(9):993-9.PMID: 12448825 [PubMed - indexed for MEDLINE]Related articles

    6.

    Abnormalities of retinal metabolism in diabetes or experimental galactosemia VIII. Prevention by aminoguanidine.

    Kowluru RA, Engerman RL, Kern TS.

    Curr Eye Res. 2000 Oct;21(4):814-9.PMID: 11120572 [PubMed - indexed for MEDLINE]Related articles

    7.

    Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia.

    Kern TS, Tang J, Mizutani M, Kowluru RA, Nagaraj RH, Romeo G, Podesta F, Lorenzi M.

    Invest Ophthalmol Vis Sci. 2000 Nov;41(12):3972-8.PMID: 11053301 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Abnormalities of retinal metabolism in diabetes or experimental galactosemia. IV. Antioxidant defense system.

    Kowluru RA, Kern TS, Engerman RL.

    Free Radic Biol Med. 1997;22(4):587-92.PMID: 9013121 [PubMed - indexed for MEDLINE]Related articles

    9.

    Comparison of retinal lesions in alloxan-diabetic rats and galactose-fed rats.

    Kern TS, Engerman RL.

    Curr Eye Res. 1994 Dec;13(12):863-7.PMID: 7720392 [PubMed - indexed for MEDLINE]Related articles

    10.

    Retinal glutamate in diabetes and effect of antioxidants.

    Kowluru RA, Engerman RL, Case GL, Kern TS.

    Neurochem Int. 2001 Apr;38(5):385-90.PMID: 11222918 [PubMed - indexed for MEDLINE]Related articles

    11.

    Potential therapeutic effect of antioxidants in experimental diabetic retina: a comparison between chronic taurine and vitamin E plus selenium supplementations.

    Di Leo MA, Ghirlanda G, Gentiloni Silveri N, Giardina B, Franconi F, Santini SA.

    Free Radic Res. 2003 Mar;37(3):323-30.PMID: 12688428 [PubMed - indexed for MEDLINE]Related articles

    12.

    Abnormalities of retinal metabolism in diabetes or galactosemia. II. Comparison of gamma-glutamyl transpeptidase in retina and cerebral cortex, and effects of antioxidant therapy.

    Kowluru R, Kern TS, Engerman RL.

    Curr Eye Res. 1994 Dec;13(12):891-6.PMID: 7720397 [PubMed - indexed for MEDLINE]Related articles

    13.

    Diabetes-induced metabolic abnormalities in myocardium: effect of antioxidant therapy.

    Kowluru RA, Engerman RL, Kern TS.

    Free Radic Res. 2000 Jan;32(1):67-74.PMID: 10625218 [PubMed - indexed for MEDLINE]Related articles

    14.

    Effect of long-term administration of alpha-lipoic acid on retinal capillary cell death and the development of retinopathy in diabetic rats.

    Kowluru RA, Odenbach S.

    Diabetes. 2004 Dec;53(12):3233-8.PMID: 15561955 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Prevention of pericyte loss by trolox in diabetic rat retina.

    Ansari NH, Zhang W, Fulep E, Mansour A.

    J Toxicol Environ Health A. 1998 Jul 24;54(6):467-75.PMID: 9661912 [PubMed - indexed for MEDLINE]Related articles

    16.

    Galactose-induced retinal microangiopathy in rats.

    Kern TS, Engerman RL.

    Invest Ophthalmol Vis Sci. 1995 Feb;36(2):490-6.PMID: 7843917 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Correction of early subnormal superior hemiretinal DeltaPO(2) predicts therapeutic efficacy in experimental diabetic retinopathy.

    Berkowitz BA, Ito Y, Kern TS, McDonald C, Hawkins R.

    Invest Ophthalmol Vis Sci. 2001 Nov;42(12):2964-9.PMID: 11687543 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Termination of experimental galactosemia in rats, and progression of retinal metabolic abnormalities.

    Kowluru RA, Koppolu P.

    Invest Ophthalmol Vis Sci. 2002 Oct;43(10):3287-91.PMID: 12356836 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Dietary antioxidant supplementation reduces lipid peroxidation but impairs vascular function in small mesenteric arteries of the streptozotocin-diabetic rat.

    Palmer AM, Thomas CR, Gopaul N, Dhir S, Anggård EE, Poston L, Tribe RM.

    Diabetologia. 1998 Feb;41(2):148-56.PMID: 9498647 [PubMed - indexed for MEDLINE]Related articles

    20.

    Retinal metabolic abnormalities in diabetic mouse: comparison with diabetic rat.

    Kowluru RA.

    Curr Eye Res. 2002 Feb;24(2):123-8.PMID: 12187484 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity